Research output per year
Research output per year
Fingerprint
Dive into the research topics where Claude Wischik is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Assessment of clinical and neuroimaging efficacy of treatment targeting tau pathology in mild cognitive impairment and mild to moderate Alzheimer’s disease with hydromethylthionine mesylate using external control data
Schelter, B. O., Shiells, H., Lo, S., Nazlee, N., Evans, E., Bentham, P., Gauthier, S., Zetterberg, H., Wilcock, G. K., Froelich, L., Burns, A., MacSweeney, E., Ballard, C., Yu, J.-T., Choon, T. S., Asvatourian, V., Muehlemann, N., Priel, J., Kook, K. & Sullivan, T. & 12 others, , Jun 2026, In: The Journal of Prevention of Alzheimer's Disease. 13, 6, 13 p., 100560.Research output: Contribution to journal › Article › peer-review
Open AccessFile6 Downloads (Pure) -
Atypical population pharmacokinetics of hydromethylthionine in patients with Alzheimer's disease explains unexpected phase 3 trial results
van Maanen, E. (Corresponding Author), Gonçalves, A., Chen, L., Fauchet, F., Cristea, S., Smith, J., Baddeley, T., Shiells, H., Hewitt, F., Schelter, B. O. & Wischik, C. M., Aug 2026, In: British Journal of Clinical Pharmacology. 92, 8, p. 2645-2656 12 p.Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Citation (Scopus) -
Timing matters: early administration of a high-affinity antibody targeting the tau repeat domain prevents aggregation in a mouse tauopathy model
Penny, L., Arastoo, M. (Corresponding Author), Lofthouse, R. A., Abdallah, A., Imoesi, P., Schwab, K., Shiells, H., Melis, V., Riedel, G., Harrington, C., Wischik, C., Porter, A. & Palliyil, S., 26 Mar 2026, In: Alzheimer's Research & Therapy. 18, 1, 20 p., 65.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Link opens in a new tab Citation (Scopus) -
Clinical, imaging and blood biomarker outcomes in a Phase 3 clinical trial of tau aggregation inhibitor hydromethylthionine mesylate in mild cognitive impairment and mild to moderate dementia due to Alzheimer’s disease
Wischik, C. M., Stefanacci, R., Bentham, P., Gauthier, S., Zetterberg, H., Wilcock, G. K., Froelich, L., Burns, A., MacSweeney, E., Ballard, C., Yu, J.-T., Choon, T. S., Asvatourian, V., Muehlemann, N., Priel, J., Kook, K., Sullivan, T., Downie, D., Miller, S. & Pringle, C. & 13 others, , Mar 2026, In: The Journal of Prevention of Alzheimer's Disease. 13, 3, 12 p., 100480.Research output: Contribution to journal › Article › peer-review
Open AccessFile4 Link opens in a new tab Citations (Scopus)2 Downloads (Pure) -
Effects of hydromethylthionine mesylate and rivastigmine in a pharmacological mouse model of Alzheimer's disease
Robinson, L., Bray, J., Melis, V., Harrington, C. R., Wischik, C. M. & Riedel, G. (Corresponding Author), Feb 2026, In: Behavioural Pharmacology. 37, 1, p. 64-69 6 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Link opens in a new tab Citations (Scopus)1 Downloads (Pure)
Datasets
-
Data from Hydromethylthionine rescues synaptic SNARE proteins in a mouse model of tauopathies: Interference by cholinesterase inhibitors
Schwab, K. (Creator), Lauer, D. (Creator), Magbagbeolu, M. (Creator), Theuring, F. (Creator), Gasiorowska, A. (Creator), Zadrozny, M. (Creator), Harrington, C. (Creator), Wischik, C. (Creator), Niewiadomska, G. (Creator) & Riedel, G. (Creator), University of Aberdeen, Jun 2024
DOI: 10.1016/j.brainresbull.2024.110955, https://ars.els-cdn.com/content/image/1-s2.0-S0361923024000881-mmc1.pdf
Dataset
Impacts
-
Discovery and commercialisation of an entirely new drug for the treatment of Alzheimer's disease
Wischik, C. (Participant), Harrington, C. (Participant), Storey, J. (Participant), Rickard, J. (Participant), Horsley, D. (Participant), Baddeley, T. (Participant), Kemp, S. (Participant), Sinclair, J. (Participant), Zabke, C. (Participant), Theuring, F. (Participant), Stamer, F. (Participant) & Marshall, C. (Participant)
Impact: Health and Wellbeing, Economic and/or Commercial
-
Discovery and development of a new drug for the treatment of dementia
Wischik, C. (Coordinator), Harrington, C. (Coordinator), Storey, J. (Participant), Rickard, J. (Participant) & Horsley, D. (Participant)
Impact: Economic and/or Commercial